Titan Medical (TSX:TMD) said today that it closed a deal with Longtai Medical to convert a $2.0 million distributorship deposit to equity. The move makes Longtai the robotic surgical company’s largest shareholder.
2015年5月，中国医疗设备分销商Ningbo Long Hengtai International Trade Co.的子公司Titan Medical和Longtai签署了一项交易，使Longtai在中国的Sport Robotic Surgical Sporting公司的独家分销商中。
According to the latest deal, Titan issued 16,892,000 shares to Longtai at 12¢ (CDN 15¢) apiece. Each unit offered is made up of one common share and one purchase warrant exercisable for a single common share at 16¢ (CDN 20¢) apiece for 60 months from the offering’s closing.
“We are very excited to become Titan’s largest shareholder and a long-term strategic partner. We look forward to working with Titan in the future development of the China and Southeast Asia markets,” Longtai CEO Feng Ting Ling said in a prepared statement when the deal was first announced.
今年7月，泰坦医疗关闭了价值近700万美元的股票对于正在开发的运动机器人辅助手术平台。
看到best minds in medtech live at DeviceTalks Boston on Oct. 2.
提交以下：机器人报告
告诉我们你的想法！